ID
23139
Beschrijving
Responsible Party: Teva Pharma GmbH ClinicalTrials.gov Identifier: NCT02384577 History of Changes Other Study ID Numbers: BFS-AS-40074 DRKS00006542 ( Registry Identifier: German Clinical Trials Register ) Study First Received: March 4, 2015 Last Updated: November 3, 2016 Study to Evaluate Satisfaction and Usability of DuoResp® SPIROMAX® in Asthma and COPD Treatment ODM derived from: https://clinicaltrials.gov/ct2/show/NCT02384577
Link
https://clinicaltrials.gov/ct2/show/NCT02384577
Trefwoorden
Versies (1)
- 25-06-17 25-06-17 -
Geüploaded op
25 juni 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Asthma and COPD Treatment DRKS00006542 NCT02384577 DRKS00006542
Eligibility Asthma and COPD Treatment NCT02384577 DRKS00006542
- StudyEvent: ODM
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Beschrijving
Contraindication
Datatype
boolean
Alias
- UMLS CUI [1]
- C1301624
Beschrijving
Study Participation Status
Datatype
boolean
Alias
- UMLS CUI [1]
- C2348568
Beschrijving
Comorbidity
Datatype
boolean
Alias
- UMLS CUI [1]
- C0009488
Beschrijving
Substance Use Disorder
Datatype
boolean
Alias
- UMLS CUI [1]
- C2702800
Beschrijving
Language Ability
Datatype
boolean
Alias
- UMLS CUI [1]
- C1145677
Beschrijving
Study planning
Datatype
boolean
Alias
- UMLS CUI [1]
- C0681871
Beschrijving
Incapable of giving informed consent
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C1550518
Similar models
Eligibility Asthma and COPD Treatment NCT02384577 DRKS00006542
- StudyEvent: ODM
C0024117 (UMLS CUI [2])
C0001644 (UMLS CUI [2,1])
C0205166 (UMLS CUI [2,2])
C1550518 (UMLS CUI [1,2])